On the Illusion of Consensus podcast, the renowned Dr. Jay Bhattacharya conducted an in-depth discussion with Sharyl about her new book, “Follow the Science: How Big Pharma Misleads, Obscures, and Prevails.” It focuses on how corruption in American healthcare is […]
The FDA has approved yet another new version of Covid vaccines. That’s despite the fact that the vaccines don’t prevent infection, transmission, or illness. Further, some researchers say evidence indicates that the more shots a person gets, the more likely
The following is an excerpt from a Medpage article. The FDA has approved Neffy, the first non-injectable epinephrine nasal spray for emergency treatment of allergic reactions, including anaphylaxis, in patients weighing at least 66 pounds. This needle-free option could help
FDA approves first emergency allergy nasal spray Read More »
A former FDA official and vaccine reviewer confirms what many suspected all along. Why haven’t heads STILL rolled? #NoAccountability Hearing here:
Still no accountability at Covid-scandal-ridden federal health agencies Read More »
A physician is suing the FDA for its lack of action to inform consumers taking selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) about potential long-term side-effects. These drugs are widely-used antidepressants. A citizen petition requests that the FDA
(READ) FDA sued for inaction on warnings about antidepressants’ sexual side effects Read More »
The following is from The Vaccine Reaction. Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines, has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States
Pfizer settles Zantac cancer lawsuits for $250 million Read More »
For whatever reason, America’s health officials haven’t seemed publicly interested in answering a crucial question: How many illnesses and deaths can be attributed to COVID versus the vaccines or some combination? Today, we look at shocking and graphic evidence that
The following is from Public Citizen. Amylyx Pharmaceuticals said on Thursday that it would withdraw AMX0035 (sodium phenylbutyrate and taurursodiol, sold as Relyvrio) from the market. A large clinical trial recently found that the drug did not provide any benefit to patients
Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy Read More »
